DK150302C - Analogifremgangsmaade til fremstilling af spiro-hydantoin-forbindelser eller farmakologisk acceptable basesalte deraf - Google Patents

Analogifremgangsmaade til fremstilling af spiro-hydantoin-forbindelser eller farmakologisk acceptable basesalte deraf

Info

Publication number
DK150302C
DK150302C DK461377A DK461377A DK150302C DK 150302 C DK150302 C DK 150302C DK 461377 A DK461377 A DK 461377A DK 461377 A DK461377 A DK 461377A DK 150302 C DK150302 C DK 150302C
Authority
DK
Denmark
Prior art keywords
spiro
analogue
preparation
acceptable bases
hydantoin compounds
Prior art date
Application number
DK461377A
Other languages
English (en)
Other versions
DK150302B (da
DK461377A (da
Inventor
Reinhard Sarges
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/767,803 external-priority patent/US4117230A/en
Application filed by Pfizer filed Critical Pfizer
Publication of DK461377A publication Critical patent/DK461377A/da
Publication of DK150302B publication Critical patent/DK150302B/da
Application granted granted Critical
Publication of DK150302C publication Critical patent/DK150302C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DK461377A 1976-10-18 1977-10-17 Analogifremgangsmaade til fremstilling af spiro-hydantoin-forbindelser eller farmakologisk acceptable basesalte deraf DK150302C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US73306276A 1976-10-18 1976-10-18
US73306276 1976-10-18
US76780377 1977-02-11
US05/767,803 US4117230A (en) 1976-10-18 1977-02-11 Hydantoin derivatives as therapeutic agents

Publications (3)

Publication Number Publication Date
DK461377A DK461377A (da) 1978-04-19
DK150302B DK150302B (da) 1987-02-02
DK150302C true DK150302C (da) 1987-09-28

Family

ID=27112515

Family Applications (1)

Application Number Title Priority Date Filing Date
DK461377A DK150302C (da) 1976-10-18 1977-10-17 Analogifremgangsmaade til fremstilling af spiro-hydantoin-forbindelser eller farmakologisk acceptable basesalte deraf

Country Status (29)

Country Link
JP (3) JPS5353653A (da)
AR (1) AR220901A1 (da)
AT (1) AT356136B (da)
AU (1) AU504978B2 (da)
BG (1) BG28847A3 (da)
CA (1) CA1088945A (da)
CH (1) CH625511A5 (da)
DD (1) DD131931A5 (da)
DE (4) DE2759927C2 (da)
DK (1) DK150302C (da)
ES (1) ES463267A1 (da)
FI (1) FI62307C (da)
FR (1) FR2367754A1 (da)
GB (1) GB1566171A (da)
GR (1) GR70201B (da)
HK (1) HK53881A (da)
IE (1) IE45805B1 (da)
IL (1) IL53094A0 (da)
KE (1) KE3167A (da)
LU (1) LU78330A1 (da)
MX (1) MX4899E (da)
MY (1) MY8200157A (da)
NL (1) NL167434C (da)
NO (1) NO148453C (da)
NZ (1) NZ185358A (da)
PH (1) PH15639A (da)
PT (1) PT67164B (da)
SE (1) SE437024B (da)
YU (1) YU40821B (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives
US4147797A (en) * 1978-08-11 1979-04-03 Pfizer Inc. Spiro-furanohydantoin derivatives
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181728A (en) * 1978-11-16 1980-01-01 Pfizer Inc. Spiro-polycyclicimidazolidinedione derivatives
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4283409A (en) * 1979-10-29 1981-08-11 Pfizer Inc. Imidazolone derivatives
US4286098A (en) * 1980-03-28 1981-08-25 Pfizer Inc. Process for the preparation of chiral hydantoins
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
EP0065392B1 (en) * 1981-05-13 1985-02-13 Imperial Chemical Industries Plc Pharmaceutical compositions containing spiro succinimide derivatives
JPS58213717A (ja) * 1982-01-20 1983-12-12 Eisai Co Ltd ヒダントイン誘導体を含有する治療用薬剤
JPS59500617A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド ヒダントイン治療剤
HU193191B (en) * 1982-12-06 1987-08-28 Pfizer Process for preparing spiro-hetero-azolones
US4474967A (en) * 1983-04-27 1984-10-02 Pfizer Inc. 8-Deutero and 8-tritio-substituted derivatives of D-4S-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione
HU198051B (en) * 1984-10-30 1989-07-28 Pfizer Process for producing spiro square brackets open imidazolidine-4,5'(6h)-quinoline square brackets closed-2,5-dione derivatives
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
JPS6357588A (ja) * 1986-08-28 1988-03-12 Sanwa Kagaku Kenkyusho Co Ltd ヒダントイン誘導体、その塩並びに該化合物を有効成分とする糖尿病合併症の予防及び治療剤
HU204832B (en) * 1987-09-04 1992-02-28 Pfizer Process for producing spiro-(imidazolidine-4,4'-pyrano/2,3-b/pyridine) derivatives and pharmaceutical compositions comprising same
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
US7439383B2 (en) 2002-04-18 2008-10-21 University Of Virginia Patent Foundation Sodium channel blockers
FR2955107B1 (fr) 2010-01-08 2012-03-02 Servier Lab Nouveaux derives thiochromanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
DE1135915B (de) * 1961-06-29 1962-09-06 Asta Werke Ag Chem Fab Verfahren zur Herstellung neuer, antikonvulsiv wirksamer Spirohydantoine
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
DE2449030A1 (de) * 1974-10-11 1976-05-20 Schering Ag Neue pyridin-derivate
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents

Also Published As

Publication number Publication date
KE3167A (en) 1981-11-06
FI62307C (fi) 1982-12-10
IE45805B1 (en) 1982-12-01
YU40821B (en) 1986-06-30
FI773060A (fi) 1978-04-19
JPS5534132B2 (da) 1980-09-04
NO773548L (no) 1978-04-19
NL7711358A (nl) 1978-04-20
AR220901A1 (es) 1980-12-15
NZ185358A (en) 1979-06-08
JPS607997B2 (ja) 1985-02-28
JPS5353653A (en) 1978-05-16
HK53881A (en) 1981-11-13
LU78330A1 (fr) 1979-06-01
JPS5940388B2 (ja) 1984-09-29
ATA745977A (de) 1979-09-15
AT356136B (de) 1980-04-10
YU244277A (en) 1982-08-31
FR2367754B1 (da) 1982-07-09
DE2746244C2 (de) 1983-05-19
GB1566171A (en) 1980-04-30
PT67164B (en) 1979-03-20
NO148453B (no) 1983-07-04
DK150302B (da) 1987-02-02
SE7711053L (sv) 1978-04-19
DE2759542C2 (da) 1988-07-07
DE2759927C2 (de) 1986-12-04
ES463267A1 (es) 1978-07-16
DD131931A5 (de) 1978-08-09
BG28847A3 (en) 1980-07-15
DE2759543C2 (da) 1987-04-09
MX4899E (es) 1982-12-14
SE437024B (sv) 1985-02-04
IE45805L (en) 1978-04-18
AU504978B2 (en) 1979-11-01
FI62307B (fi) 1982-08-31
DK461377A (da) 1978-04-19
NO148453C (no) 1983-10-12
AU2943177A (en) 1979-04-12
JPS5495575A (en) 1979-07-28
DE2746244A1 (de) 1978-04-20
FR2367754A1 (fr) 1978-05-12
JPS5495570A (en) 1979-07-28
IL53094A0 (en) 1977-12-30
NL167434B (nl) 1981-07-16
CA1088945A (en) 1980-11-04
NL167434C (nl) 1981-12-16
CH625511A5 (en) 1981-09-30
MY8200157A (en) 1982-12-31
GR70201B (da) 1982-08-31
PH15639A (en) 1983-03-11
PT67164A (en) 1977-11-01

Similar Documents

Publication Publication Date Title
DK150302C (da) Analogifremgangsmaade til fremstilling af spiro-hydantoin-forbindelser eller farmakologisk acceptable basesalte deraf
DK142372C (da) Fremgangsmaade til fremstilling af androstan-17-on-derivater
DK30277A (da) Fremgangsmade til fremstilling af substituerede phenylamidiner
DK148477C (da) Analogifremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK146542C (da) Analogifremgangsmaade til fremstilling af daunosaminylanthracyclioner
DK46777A (da) Fremgangsmade til fremstilling af meta-aryloxybenzaldehyder
DK113476A (da) Fremgangsmade til fremstilling af amoxicillintrihydrat
DK244577A (da) Fremgangsmade til fremstilling af hydantoinderivater
DK178677A (da) Fremgangsmade til fremstilling af adeninderivater
DK271977A (da) Fremgangsmade til fremstilling af dispeptidderivater
DK339677A (da) Fremgangsmade til fremstilling af 2-benzylpyrrolidiner
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK46577A (da) Fremgangsmade til fremstilling af tetrahydroechinocandinderivater
DK118177A (da) Fremgangsmade til fremstilling af isobutyramidderivater
DK144377A (da) Fremgangsmade til fremstilling af acylcyanider
DK144793C (da) Analogifremgangsmaade til fremstilling af dihydro- eller tetrahydroiminothiaziner eller farmaceutisk acceptable syreadditionssalte deraf
DK88777A (da) Fremgangsmade til fremstilling af substituerede azapuriner
DK146718C (da) Analogifremgangsmaade til fremstilling af benzobicyklononener
DK271377A (da) Fremgangsmade til fremstilling af substituerede arylacetamidocephalosporiner
DK144277A (da) Fremgangsmade til fremstilling af acylcyanider
DK143752C (da) Analogifremgangsmaade til fremstilling af pyridobenzodiazepinoner eller farmakologisk acceptable salte deraf
DK264377A (da) Fremgangsmade til fremstilling af 1alfa-hydroxycholesterol-derivater
DK147280C (da) Analogifremgangsmaade til fremstilling af 4-amino-benzo(b)bicyklo(3,3,1)nonenderivater
DK143750C (da) Analogifremgangsmaade til fremstilling af 1,2,3,4-tetrahydroisoquinoliner
DK196577A (da) Fremgangsmade til fremstilling af kolecystokinin-pankreozymin-oktapeptidamidsulfatester

Legal Events

Date Code Title Description
PBP Patent lapsed